Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
about
Incidental Findings with Genomic Testing: Implications for Genetic Counseling PracticeGenetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plansEvidence synthesis and guideline development in genomic medicine: current status and future prospectsActionable exomic incidental findings in 6503 participants: challenges of variant classificationGenomic sequencing: assessing the health care system, policy, and big-data implications.Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results.A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories.Lost in translation: returning germline genetic results in genome-scale cancer researchReturning individual research results for genome sequences of pancreatic cancer.Refining the structure and content of clinical genomic reportsAttitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing.Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.Return of genomic results to research participants: the floor, the ceiling, and the choices in between.Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromesClinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Living laboratory: whole-genome sequencing as a learning healthcare enterprise.A one-page summary report of genome sequencing for the healthy adultFlexible positions, managed hopes: the promissory bioeconomy of a whole genome sequencing cancer study.Genomic screening of the general adult population: key concepts for assessing net benefit with systematic evidence reviews.Managing the Ethical Issues of Genomic Research using Pathology Specimens.The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.Perspectives on genetic and genomic technologies in an academic medical center: the duke experienceThe IGNITE network: a model for genomic medicine implementation and research.A Clinical Service to Support the Return of Secondary Genomic Findings in Human Research.Parlez-vous VUS?Illustrative case studies in the return of exome and genome sequencing results.Patients' views on incidental findings from clinical exome sequencing.A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencingAutomatic Placement of Genomic Research Results in Medical Records: Do Researchers Have a Duty? Should Participants Have a Choice?Towards a European consensus for reporting incidental findings during clinical NGS testing.Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencingAdolescent perspectives on the return of individual results in genomic addiction research.A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record.Whole exome or genome sequencing: nurses need to prepare families for the possibilities.Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing.Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing.Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium.Using omics approaches to understand pulmonary diseases.
P2860
Q26777211-03055D71-C73E-4BC7-A7D9-48BE2638FF4AQ26801647-89359AF7-04C6-4236-B05D-C09E33E9EBBEQ27010101-5DB1C53C-BEF5-4A49-91CB-5376EC31F9F5Q30300875-DD348B14-1C8C-48E9-B079-407BA7F59BCEQ30835712-2372D022-4513-49D1-A2E3-CA54B4D53E68Q30839925-D7264C29-7CF8-4834-80C2-792152DD2ADDQ30847688-DB334460-EABD-4F03-A04A-A25900927470Q33613050-6B45A5EE-CE96-4601-A906-758ED4652BCBQ33796388-138092AE-69F8-4DB8-8881-69DF1B4F4AEEQ33830276-928B9F16-8E44-4A78-8D1C-54968AB91CB8Q33858610-93D33DCD-FE15-44B1-8428-4EF3190FFD2AQ33902567-7442C607-55AD-424B-9336-51869298BC7CQ34000877-7A961C7C-3C7F-41A1-827D-B522E0FDFDF4Q34243496-167D3F5E-2EC6-43DA-B515-2A13CC9864BAQ34526631-70E4D7F9-975D-4DFF-A524-5F66991BD842Q34995956-A8A64155-02D6-4EBD-9B14-6E563605FBA1Q35143268-69438B82-25BF-4BE0-9AD9-62F625DF1BA4Q35187045-5467C81E-1C56-45B9-9B49-2C352D9CE1ABQ35287751-44993A86-33EF-4E85-825E-C60875B75F78Q35482477-C79E5445-1122-4B93-BDEA-AA853559BA97Q35602902-95CE43A0-D1E7-4559-B7B6-4983748FBB29Q35722718-878E664B-8D54-431A-A4C8-539D09E17B27Q35824422-49FA16DA-B042-4BE5-9CA2-A056ACF6E819Q35884676-AB949160-8202-456F-B176-E948954B9959Q35945780-6F8F7F48-A3E4-4DC7-B45E-FB3BA9B62C4AQ36084279-883F72B3-B6AE-4370-9952-E01E26BAFC47Q36166145-989E971D-6559-452C-89A5-23412F3B9E16Q36556501-E3927346-B75A-467E-A5B0-28599A35AB4FQ36578258-C9FF6B81-8E97-4286-A8EE-2D7D378BD25DQ36658240-880BE1FA-FD94-4952-9F87-33CB1EC278BBQ36695676-A46B50E1-65D8-498E-8AD2-1A920E15F5A8Q37156736-6B11270B-8E6E-462F-8B84-7787D2FC284CQ37391158-258918C4-6B28-4F70-958A-688BEA6CE801Q37633177-CDCA4B0B-C383-4FE5-8241-7F2DCEF034CBQ38245057-41576A53-FE90-48E6-8A64-DC789DF9C571Q38252010-B34C3FBD-8507-4065-9F9B-DD53F68B3AB5Q38283979-EB10304E-9295-412C-9B61-106D957D60ACQ38562550-A0A77B90-F932-4FDC-8F2B-05307559F5F9Q38600110-E839ECFE-B6C9-4A2C-9A4F-C522C3BADD88Q38642884-B4C210D0-CB5B-460C-AE9A-96E42D4E7AB8
P2860
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Processes and preliminary outp ...... ploratory Research Consortium.
@ast
Processes and preliminary outp ...... ploratory Research Consortium.
@en
type
label
Processes and preliminary outp ...... ploratory Research Consortium.
@ast
Processes and preliminary outp ...... ploratory Research Consortium.
@en
prefLabel
Processes and preliminary outp ...... ploratory Research Consortium.
@ast
Processes and preliminary outp ...... ploratory Research Consortium.
@en
P2093
P2860
P50
P356
P1433
P1476
Processes and preliminary outp ...... ploratory Research Consortium.
@en
P2093
Christine Eng
Elizabeth T DeChene
Fuki M Hisama
James P Evans
Jonathan S Berg
Laura M Amendola
Matthew C Dulik
Members of the CSER Actionability and Return of Results Working Group
Nancy B Spinner
Nikhil Wagle
P2860
P2888
P304
P356
10.1038/GIM.2013.133
P407
P577
2013-10-24T00:00:00Z